$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Guillain–Barré syndrome: a century of progress 원문보기

Nature reviews. Neurology, v.12 no.12, 2016년, pp.723 - 731  

Goodfellow, John A. (Neuroimmunology Laboratory, Laboratory Building, Queen Elizabeth University Hospital, Glasgow, G51 4TF, Scotland, UK.) ,  Willison, Hugh J. (Institute of Infection, Immunity and Inflammation, University of Glasgow, University Place, Glasgow, G12 8TA, Scotland, UK.)

Abstract AI-Helper 아이콘AI-Helper

In 1916, Guillain, Barré and Strohl reported on two cases of acute flaccid paralysis with high cerebrospinal fluid protein levels and normal cell counts — novel findings that identified the disease we now know as Guillain–Barré syndrome (GBS). 100 years on, we have made gre...

참고문헌 (98)

  1. Gaz. Hebd. Méd. Chir. O Landry 6 472 1859 Landry, O. Note sur la paralysie ascendante aiguë. Gaz. Hebd. Méd. Chir. 6, 472-474, 486-488 (in French) (1859). 

  2. Ann. Med. Interne (Paris) G Guillain 150 24 1999 Guillain, G., Barré, J. A. & Strohl, A. Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916. Ann. Med. Interne (Paris) 150, 24-32 (in French) (1999). 

  3. J. Neurol. Neurosurg. Psychiatry JM Pearce 57 179 1994 10.1136/jnnp.57.2.179 Pearce, J. M. Walter Essex Wynter, Quincke, and lumbar puncture. J. Neurol. Neurosurg. Psychiatry 57, 179 (1994). 

  4. Brain C Fokke 137 33 2014 10.1093/brain/awt285 Fokke, C. et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 137, 33-43 (2014). 

  5. Rev. Neurol. S Draganescu 2 517 1927 Draganescu, S. & Claudian, J. Sur un cas de radiculo-névrite curable (syndrome de Guillain-Barré). Rev. Neurol. 2, 517-521 (in French) (1927). 

  6. Medicine (Baltimore) WE Haymaker 28 59 1949 10.1097/00005792-194902010-00003 Haymaker, W. E. & Kernohan, J. W. The Landry-Guillain-Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore) 28, 59-141 (1949). 

  7. J. Exp. Med. BH Waksman 102 213 1955 10.1084/jem.102.2.213 Waksman, B. H. & Adams, R. D. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J. Exp. Med. 102, 213-236 (1955). 

  8. J. Pathol. Bacteriol. KE Astrom 83 89 1962 10.1002/path.1700830112 Astrom, K. E. & Waksman, B. H. The passive transfer of experimental allergic encephalomyelitis and neuritis with living lymphoid cells. J. Pathol. Bacteriol. 83, 89-106 (1962). 

  9. Nature M Kadlubowski 277 140 1979 10.1038/277140a0 Kadlubowski, M. & Hughes, R. A. Identification of the neuritogen for experimental allergic neuritis. Nature 277, 140-141 (1979). 

  10. J. Immunol. C Linington 133 1946 1984 Linington, C. et al. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J. Immunol. 133, 1946-1950 (1984). 

  11. J. Neuroimmunol. W Yan 277 13 2014 10.1016/j.jneuroim.2014.09.012 Yan, W. et al. Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis. J. Neuroimmunol. 277, 13-17 (2014). 

  12. Medicine (Baltimore) AK Asbury 48 173 1969 10.1097/00005792-196905000-00001 Asbury, A. K., Arnason, B. G. & Adams, R. D. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48, 173-215 (1969). 

  13. Arch. Neurol. H Wis´niewski 21 269 1969 10.1001/archneur.1969.00480150059008 Wis´niewski, H., Terry, R. D., Whitaker, J. N., Cook, S. D. & Dowling, P. C. Landry-Guillain-Barré syndrome. A primary demyelinating disease. Arch. Neurol. 21, 269-276 (1969). 

  14. Lab. Invest. JW Prineas 26 133 1972 Prineas, J. W. Acute idiopathic polyneuritis. An electron microscope study. Lab. Invest. 26, 133-147 (1972). 

  15. Clin. Neuropathol. C Brechenmacher 6 19 1987 Brechenmacher, C. et al. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin. Neuropathol. 6, 19-24 (1987). 

  16. N. Engl. J. Med. M Fisher 255 57 1956 10.1056/NEJM195607122550201 Fisher, M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255, 57-65 (1956). 

  17. J. Neurol. Neurosurg. Psychiatry N Shahrizaila 84 576 2013 10.1136/jnnp-2012-302824 Shahrizaila, N. & Yuki, N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J. Neurol. Neurosurg. Psychiatry 84, 576-583 (2013). 

  18. Am. J. Epidemiol. LB Schonberger 110 105 1979 10.1093/oxfordjournals.aje.a112795 Schonberger, L. B. et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am. J. Epidemiol. 110, 105-123 (1979). 

  19. Arch. Neurol. LT Kurland 42 1089 1985 10.1001/archneur.1985.04060100075026 Kurland, L. T., Wiederholt, W. C., Kirkpatrick, J. W., Potter, H. G. & Armstrong, P. Swine influenza vaccine and Guillain-Barré syndrome. Epidemic or artifact? Arch. Neurol. 42, 1089-1090 (1985). 

  20. Am. J. Epidemiol. AD Langmuir 119 841 1984 10.1093/oxfordjournals.aje.a113809 Langmuir, A. D., Bregman, D. J., Kurland, L. T., Nathanson, N. & Victor, M. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am. J. Epidemiol. 119, 841-879 (1984). 

  21. N. Engl. J. Med. T Lasky 339 1797 1998 10.1056/NEJM199812173392501 Lasky, T. et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N. Engl. J. Med. 339, 1797-1802 (1998). 

  22. N. Engl. J. Med. LD Osler 262 964 1960 10.1056/NEJM196005122621905 Osler, L. D. & Sidell, A. D. The Guillain-Barre syndrome; the need for exact diagnostic criteria. N. Engl. J. Med. 262, 964-969 (1960). 

  23. 10.1002/ana.410030628 [No authors listed.] Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3, 565-566 (1978). 

  24. Ann. Neurol. AK Asbury 9 Suppl. 1 1981 10.1002/ana.410090703 Asbury, A. K. Diagnostic considerations in Guillain-Barré syndrome. Ann. Neurol. 9 (Suppl.), 1-5 (1981). 

  25. Ann. Neurol. AK Asbury 27 Suppl. S21 1990 10.1002/ana.410270707 Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27 (Suppl.), S21-S24 (1990). 

  26. Trends Biochem. Sci. CL Schengrund 40 397 2015 10.1016/j.tibs.2015.03.007 Schengrund, C. L. Gangliosides: glycosphingolipids essential for normal neural development and function. Trends Biochem. Sci. 40, 397-406 (2015). 

  27. Proc. Natl Acad. Sci. USA JC Dodge 112 8100 2015 10.1073/pnas.1508767112 Dodge, J. C. et al. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 112, 8100-8105 (2015). 

  28. Neurosci. Lett. Y Nagai 2 107 1976 10.1016/0304-3940(76)90033-1 Nagai, Y., Momoi, T., Saito, M., Mitsuzawa, E. & Ohtani, S. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci. Lett. 2, 107-111 (1976). 

  29. Neuroepidemiology E Díez-Tejedor 12 251 1993 10.1159/000110325 Díez-Tejedor, E., Gutiérrez-Rivas, E. & Gil-Peralta, A. Gangliosides and Guillain-Barré syndrome: the Spanish data. Neuroepidemiology 12, 251-256 (1993). 

  30. Neuroepidemiology J Matias-Guiu 12 58 1993 10.1159/000110301 Matias-Guiu, J. et al. Incidence of Guillain-Barré syndrome and ganglioside intake in Alcoi, Spain. Neuroepidemiology 12, 58-60 (1993). 

  31. N. Engl. J. Med. FH Geisler 324 1829 1991 10.1056/NEJM199106273242601 Geisler, F. H., Dorsey, F. C. & Coleman, W. P. Recovery of motor function after spinal-cord injury - a randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 324, 1829-1838 (1991). 

  32. Mayo Clin. Proc. W Wiederholt 39 427 1964 Wiederholt, W., Mulder, D. & Lambert, E. The Landry-Guillain-Barre-Strohl syndrome or polyradiculoneuropathy: historical review, report on 97 patients, and present concepts. Mayo Clin. Proc. 39, 427-451 (1964). 

  33. Ann. Neurol. AJ Sumner 11 469 1982 10.1002/ana.410110506 Sumner, A. J., Saida, K., Saida, T., Silberberg, D. H. & Asbury, A. K. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann. Neurol. 11, 469-477 (1982). 

  34. J. Physiol. S Lafontaine 323 287 1982 10.1113/jphysiol.1982.sp014073 Lafontaine, S., Rasminsky, M., Saida, T. & Sumner, A. J. Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum. J. Physiol. 323, 287-306 (1982). 

  35. Ann. Neurol. T Saida 11 69 1982 10.1002/ana.410110112 Saida, T. et al. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann. Neurol. 11, 69-75 (1982). 

  36. Muscle Nerve JW Albers 8 528 1985 10.1002/mus.880080609 Albers, J. W., Donofrio, P. D. & McGonagle, T. K. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 8, 528-539 (1985). 

  37. Ann. Neurol. JG McLeod 9 Suppl. 20 1981 10.1002/ana.410090705 McLeod, J. G. Electrophysiological studies in the Guillain-Barré syndrome. Ann. Neurol. 9 (Suppl.), 20-27 (1981). 

  38. Clin. Neurophysiol. A Uncini 123 1487 2012 10.1016/j.clinph.2012.01.025 Uncini, A. & Kuwabara, S. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin. Neurophysiol. 123, 1487-1495 (2012). 

  39. Brain TE Feasby 109 1115 1986 10.1093/brain/109.6.1115 Feasby, T. E. et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 109, 1115-1126 (1986). 

  40. Neurology TE Feasby 37 357 1987 10.1212/WNL.37.2.357-b Feasby, T. E. et al. Acute “axonal” Guillain-Barré polyneuropathy. Neurology 37, 357 (1987). 

  41. Neurology N Yuki 40 1900 1990 10.1212/WNL.40.12.1900 Yuki, N., Yoshino, H., Sato, S. & Miyatake, T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40, 1900-1902 (1990). 

  42. Ann. Neurol. C Hafer-Macko 40 635 1996 10.1002/ana.410400414 Hafer-Macko, C. et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40, 635-644 (1996). 

  43. Lancet GM McKhann 338 593 1991 10.1016/0140-6736(91)90606-P McKhann, G. M. et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 338, 593-597 (1991). 

  44. J. Neurocytol. JW Griffin 25 33 1996 10.1007/BF02284784 Griffin, J. W. et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J. Neurocytol. 25, 33-51 (1996). 

  45. Ann. Neurol. CE Hafer-Macko 39 625 1996 10.1002/ana.410390512 Hafer-Macko, C. E. et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39, 625-635 (1996). 

  46. Annu. Rev. Neurosci. TW Ho 21 187 1998 10.1146/annurev.neuro.21.1.187 Ho, T. W., McKhann, G. M. & Griffin, J. W. Human autoimmune neuropathies. Annu. Rev. Neurosci. 21, 187-226 (1998). 

  47. Proc. R. Soc. Med. A Campbell 51 157 1958 Campbell, A. The aetiology of polyneuritis. Proc. R. Soc. Med. 51, 157-159 (1958). 

  48. Br. Med. J. (Clin. Res. Ed.) KM Rhodes 285 173 1982 10.1136/bmj.285.6336.173 Rhodes, K. M. & Tattersfield, A. E. Guillain-Barré syndrome associated with Campylobacter infection. Br. Med. J. (Clin. Res. Ed.) 285, 173-174 (1982). 

  49. Br. Med. J. (Clin. Res. Ed.) J Kaldor 288 1867 1984 10.1136/bmj.288.6434.1867 Kaldor, J. & Speed, B. R. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br. Med. J. (Clin. Res. Ed.) 288, 1867-1870 (1984). 

  50. N. Engl. J. Med. JH Rees 333 1374 1995 10.1056/NEJM199511233332102 Rees, J. H., Soudain, S. E., Gregson, N. A. & Hughes, R. A. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333, 1374-1379 (1995). 

  51. J. Exp. Med. N Yuki 178 1771 1993 10.1084/jem.178.5.1771 Yuki, N. et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178, 1771-1775 (1993). 

  52. Ann. Neurol. N Yuki 36 791 1994 10.1002/ana.410360517 Yuki, N. et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36, 791-793 (1994). 

  53. Proc. Natl Acad. Sci. USA N Yuki 101 11404 2004 10.1073/pnas.0402391101 Yuki, N. et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl Acad. Sci. USA 101, 11404-11409 (2004). 

  54. Ann. Neurol. AA Ilyas 23 440 1988 10.1002/ana.410230503 Ilyas, A. A. et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann. Neurol. 23, 440-447 (1988). 

  55. J. Neurol. NA Gregson 238 447 1991 10.1007/BF00314652 Gregson, N. A., Jones, D., Thomas, P. K. & Willison, H. J. Acute motor neuropathy with antibodies to GM1 ganglioside. J. Neurol. 238, 447-451 (1991). 

  56. Ann. Neurol. TW Ho 45 168 1999 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 Ho, T. W. et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45, 168-173 (1999). 

  57. J. Neurol. Neurosurg. Psychiatry CP O'Leary 61 649 1996 10.1136/jnnp.61.6.649 O'Leary, C. P. et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry 61, 649-651 (1996). 

  58. Ann. Neurol. A Chiba 31 677 1992 10.1002/ana.410310619 Chiba, A., Kusunoki, S., Shimizu, T. & Kanazawa, I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31, 677-679 (1992). 

  59. Ann. Neurol. K Kaida 56 567 2004 10.1002/ana.20222 Kaida, K. et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann. Neurol. 56, 567-571 (2004). 

  60. Neurology A Pestronk 48 1104 1997 10.1212/WNL.48.4.1104 Pestronk, A., Choksi, R., Blume, G. & Lopate, G. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone. Neurology 48, 1104-1106 (1997). 

  61. PLoS ONE S Rinaldi 8 e82337 2013 10.1371/journal.pone.0082337 Rinaldi, S. et al. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome. PLoS ONE 8, e82337 (2013). 

  62. Prog. Lipid Res. S Rinaldi 49 87 2010 10.1016/j.plipres.2009.09.001 Rinaldi, S., Brennan, K. M. & Willison, H. J. Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. Prog. Lipid Res. 49, 87-95 (2010). 

  63. Methods Mol. Biol. S Rinaldi 808 413 2012 10.1007/978-1-61779-373-8_28 Rinaldi, S., Brennan, K. M. & Willison, H. J. Combinatorial glycoarray. Methods Mol. Biol. 808, 413-423 (2012). 

  64. J. Infect. Dis. HJ Willison 176 Suppl. 2 S144 1997 10.1086/513799 Willison, H. J. et al. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. J. Infect. Dis. 176 (Suppl. 2), S144-S149 (1997). 

  65. J. Clin. Invest. KN Greenshields 119 595 2009 10.1172/JCI37338 Greenshields, K. N. et al. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J. Clin. Invest. 119, 595-610 (2009). 

  66. Neurology A Chiba 43 1911 1993 10.1212/WNL.43.10.1911 Chiba, A., Kusunoki, S., Obata, H., Machinami, R. & Kanazawa, I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43, 1911-1917 (1993). 

  67. J. Neurosci. JA Goodfellow 25 1620 2005 10.1523/JNEUROSCI.4279-04.2005 Goodfellow, J. A. et al. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J. Neurosci. 25, 1620-1628 (2005). 

  68. Brain R McGonigal 133 1944 2010 10.1093/brain/awq119 McGonigal, R. et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133, 1944-1960 (2010). 

  69. J. Neurosci. K Susuki 27 3956 2007 10.1523/JNEUROSCI.4401-06.2007 Susuki, K. et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27, 3956-3967 (2007). 

  70. Brain SK Halstead 127 2109 2004 10.1093/brain/awh231 Halstead, S. K. et al. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127, 2109-2123 (2004). 

  71. Brain GM O'Hanlon 124 893 2001 10.1093/brain/124.5.893 O'Hanlon, G. M. et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain 124, 893-906 (2001). 

  72. Ann. Neurol. SK Halstead 58 203 2005 10.1002/ana.20546 Halstead, S. K. et al. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann. Neurol. 58, 203-210 (2005). 

  73. Acta Neuropathol. Commun. R McGonigal 4 23 2016 10.1186/s40478-016-0291-x McGonigal, R. et al. C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy. Acta Neuropathol. Commun. 4, 23 (2016). 

  74. Neurology S Kusunoki 57 736 2001 10.1212/WNL.57.4.736 Kusunoki, S., Shiina, M. & Kanazawa, I. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry. Neurology 57, 736-738 (2001). 

  75. Lancet VM Cao-Lormeau 387 1531 2016 10.1016/S0140-6736(16)00562-6 Cao-Lormeau, V. M. et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531-1539 (2016). 

  76. Arq. Neuropsiquiatr. LM Araujo 74 253 2016 10.1590/0004-282X20160035 Araujo, L. M., Ferreira, M. L. & Nascimento, O. J. Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil. Arq. Neuropsiquiatr. 74, 253-255 (2016). 

  77. Ann. Neurol. MK White 80 479 2016 10.1002/ana.24748 White, M. K., Wollebo, H. S., David Beckham, J., Tyler, K. L. & Khalili, K. Zika virus: an emergent neuropathological agent. Ann. Neurol. 80, 479-489 (2016). 

  78. N. Engl. J. Med. B Parra 375 1513 2016 10.1056/NEJMoa1605564 Parra, B. et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375, 1513-1523 (2016). 

  79. Lancet RJ Greenwood 1 877 1984 10.1016/S0140-6736(84)91341-2 Greenwood, R. J. et al. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1, 877-879 (1984). 

  80. Lancet PO Osterman 2 1296 1984 10.1016/S0140-6736(84)90819-5 Osterman, P. O. et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 2, 1296-1299 (1984). 

  81. 10.1212/WNL.35.8.1096 [No authors listed.] Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group. Neurology 35, 1096-1104 (1985). 

  82. 10.1002/ana.410220612 [No authors listed.] Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Ann. Neurol. 22, 753-761 (1987). 

  83. Neurology PA van Doorn 40 209 1990 10.1212/WNL.40.2.209 van Doorn, P. A., Brand, A., Strengers, P. F., Meulstee, J. & Vermeulen, M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 40, 209-212 (1990). 

  84. Neurology RP Kleyweg 38 1639 1988 10.1212/WNL.38.10.1639 Kleyweg, R. P., van der Meché, F. G. & Meulstee, J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology 38, 1639-1641 (1988). 

  85. J. Neurol. Sci. M Vermeulen 70 317 1985 10.1016/0022-510X(85)90173-X Vermeulen, M., van der Meché, F. G., Speelman, J. D., Weber, A. & Busch, H. F. Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J. Neurol. Sci. 70, 317-326 (1985). 

  86. N. Engl. J. Med. FG van der Meché 326 1123 1992 10.1056/NEJM199204233261705 van der Meché, F. G. & Schmitz, P. I. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N. Engl. J. Med. 326, 1123-1129 (1992). 

  87. Cochrane Database Syst. Rev. RA Hughes 9 CD002063 2014 Hughes, R. A., Swan, A. V. & van Doorn, P. A. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst. Rev. 9, CD002063 (2014). 

  88. Neurology B van den Berg 80 1650 2013 10.1212/WNL.0b013e3182904fcc van den Berg, B., Bunschoten, C., van Doorn, P. A. & Jacobs, B. C. Mortality in Guillain-Barre syndrome. Neurology 80, 1650-1654 (2013). 

  89. 10.1016/S0140-6736(96)09095-2 [No authors listed.] Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet 349, 225-230 (1997). 

  90. Lancet R van Koningsveld 363 192 2004 10.1016/S0140-6736(03)15324-X van Koningsveld, R. et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet 363, 192-196 (2004). 

  91. 10.1016/0140-6736(93)90351-G [No authors listed.] Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Guillain-Barré Syndrome Steroid Trial Group. Lancet 341, 586-590 (1993). 

  92. Cochrane Database Syst. Rev. RA Hughes 8 CD001446 2012 Hughes, R. A. & van Doorn, P. A. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst. Rev. 8, CD001446 (2012). 

  93. Netherlands Trial Register. trialregister.nl http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2224 (2016) 

  94. J. Physiol. JJ Plomp 587 3979 2009 10.1113/jphysiol.2009.171702 Plomp, J. J. & Willison, H. J. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J. Physiol. 587, 3979-3999 (2009). 

  95. Brain SK Halstead 131 1197 2008 10.1093/brain/awm316 Halstead, S. K. et al. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131, 1197-1208 (2008). 

  96. J. Peripher. Nerv. Syst. AM Fitzpatrick 16 84 2011 10.1111/j.1529-8027.2011.00328.x Fitzpatrick, A. M. et al. An open label clinical trial of complement inhibition in multifocal motor neuropathy. J. Peripher. Nerv. Syst. 16, 84-91 (2011). 

  97. US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02029378 (2014). 

  98. US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT02493725 (2016). 

관련 콘텐츠

오픈액세스(OA) 유형

GREEN

저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로